Osteochondrosis: Pathogenetic Bioregulatory Limitations of Using the Drug Discus Compositum
Journal Title: Біль. Суглоби. Хребет - Year 2016, Vol 2, Issue 22
Abstract
Treatment of osteochondrosis is one of the actual problems in the therapy of degenerative-dystrophic diseases of the musculoskeletal system [1]. The clinical studies have shown that osteochondrosis — a disease of the whole body, and therefore, interdisciplinary problem, relevant both for neurologists, as well as for orthopedists and general practitioners [2]. A brief review of clinical studies is presented demonstrating the relevance of using bioregulatory approach, Discus compositum and other combined bioregulatory drugs (CBD) [3–6]. The feature of CBD — the content of ultra-low doses (low dose, very-low dose antigen) of active substances that contribute to the recovery of the processes of self-regulation and detoxification in the body, activation of metabolism and regeneration/reparation processes. Bioregulatory action of CBD complements the effect of other medicines, combining well with them. Since the ultra-small doses are not metabolized in the body, CBD have no pharmacokinetics: they do not require additional energy and do not have a pharmacological stress on the body [3–6]. In this regard, they are well-tolerated by patients during chronic administration. Also, their application is helpful, if there are contraindications, side effects and the risk of complications when using other groups of drugs.
Authors and Affiliations
L. О. Vakulenko, S. V. Popovych
Keywords
Related Articles
- EP ID EP209365
- DOI 10.22141/2224-1507.2.22.2016.75761
- Views 72
- Downloads 0
Age and Sex Features of Proximal Hip Geometry in Patients with its Intraarticular Fractures
According to the literature data, some parameters of the femoral bone (FB), namely the length of its axis, head-collum-diaphyseal angle, etc., are independent predictors of proximal femoral (PF) fractures, but such studi...
Information Support of Evidence-Based Health Care. Part III
The article presents the features of the development, systematization and use of such secondary sources of epidemiological evidences as guidelines and decision analysis. The sources, classification and role of economic e...
Some key aspects of the IOF-ESCEO World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases — 2019 (April 4–7, Paris, France)
.
Long-Term Use of Bonviva® for the Treatment of Postmenopausal Osteoporosis: New Evidence
Osteoporosis is a disease of great social importance. Its treatment is a complicated problem and is associated with low compliance and a risk for adverse reactions. Ibandronate belongs to a group of bisphosphonates. The...
Studying the efficacy and safety of dietary supplement Olidetrim in the correction of vitamin D deficiency in postmenopausal women
Background. Today, vitamin D deficiency and insufficiency is a global problem of public health affecting an estimated 1 billion people worldwide. Numerous studies show that the biological effects of vitamin D are not lim...